Kristof Cuppens

Hasselt University

Belgium

Research Interests

Explore related searches

Professors in Belgium Professors in Immunology Immunology professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (4)

Henning Reis

Professor of Molecular Pathology

Klinikum der Johann Wolfgang Goethe-Universität Frankfurt

GERMANY

View details

Marcel Wiesweg

University Hospital Essen

GERMANY

View details

Harry J.M. Groen

Prof.dr.

University Medical Center Groningen

NETHERLANDS

View details

Brigitte Maes

Hasselt University

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kristof Cuppens

Research Interests

Explore related searches

Contact this professor

Articles (10)

Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial.

The Adenosinergic Pathway in Non-Small Cell Lung Cancer

Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial

Immune checkpoint inhibition in early-stage non-small cell lung cancer

Immune checkpoint inhibition in early-stage non-small cell lung cancer

PDC*lung01: An innovative therapeutic cancer vaccine induces specific immune responses in combination with anti- PD-1 treatment in patients with non-small cell lung cancer

Preliminary clinical results of a therapeutic cancer vaccine PDC*lung01 in combination with anti-PD-1 in patients (pts) with stage IV NSCLC

Reliability of panel-based mutational signatures for immune-checkpoint-inhibition efficacy prediction in non-small cell lung cancer

Sjögren’s Syndrome Caused by PD-1 Inhibition in a Lung Cancer Patient

Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1-High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial

Collaborators (4)

Henning Reis

Marcel Wiesweg

Harry J.M. Groen

Brigitte Maes

Make your next move.